0 Items - $0.00
A to Z


N6- (2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ), sodium salt

Cat. No.: P 012
CAS No.: [181705-62-4]
Shipping: Dry ice
Product Name Price (net) Qty
Cat. No.: P 012-05
Unit: 5 µmol / ~3.1 mg

For other salt forms or a guaranteed higher purity please inquire. Analogue useful for specific interaction with modified receptor proteins (chemical genetics approach) and for studying CFTR gating. The corresponding diphosphate (Cat. No. P 013) is offered as well. Detailed technical information available. References: Gillespie et al., J. Biol. Chem., 274, 31373 - 31381 (1999); Jih et al., J. Physiol., 589, 2719 - 2731 (2011).


Vial containing 500 µl of 10 mM aqueous solution of pH 7.6

Cat. No. P 012
CAS number [181705-62-4]
Purity > 95% HPLC
Salt form Sodium
Appearance 10 mM aqueous solution of pH 7.6
Storage temperature -70°C / -94°F
Molecular formula C₁₈H₂₄N₅O₁₃P₃ (free acid)
Molecular weight [g/mol] 611.3 (free acid)
Absorption max [nm] 269
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 20500
  • 1. Chen X., Zhao X., Abeyweera T. P.Rotenberg S. A., Biochemistry, 51, 7087 - 7097 (2012), "Analysis of Substrates of Protein Kinase C Isoforms in Human Breast Cells by the Traceable Kinase Method"
  • 2. Jih K.-Y., Li M., Hwang T.-C.Bompadre S. G., J. Physiol., 589, 2719 - 2731 (2011), "The Most Common Cystic Fibrosis-associated Mutation Destabilizes the Dimeric State of Nucleotide-binding Domains of CFTR"
  • 3. Miki H., Zhou Z., Li M., Hwang T.-C.Bompadre S. G., J. Biol. Chem., 285, 19967 - 19975 (2010), "Potentiation of Disease-associated Cystic Fibrosis Transmembrane Conductance Regulator Mutants by Hydrolyzable ATP Analogs"
  • 4. Chi Y., Welcker M., Hizli A. A., Posakony J. P., Aebersold R.Clurman B. E., Genome Biology, 9, 0 - 0 (2008), "Identification of CDK2 Substrates in Human Cell Lysates"
  • 5. Zhou Z., Wang X., Li M., Sohma Y., Zou X.Hwang T.-C., J. Physiol., 569, 447 - 457 (2005), "High Affinity ATP/ADP Analogues as New Tools for Studying CFTR Gating"
  • 6. Provance D. W., Gourley C. R., Silan C. M., Cameron L. C., Shokat K. M., Goldenring J. R., Shah K., Gillespie P. G.Mercer J. A., Proc. Natl. Acad. Sci., 101, 1868 - 1873 (2004), "Chemical-genetic Inhibition of a Sensitized Mutant Myosin Vb Demonstrates a Role in Peripheral-pericentriolar Membrane Traffic"
  • 7. Wan L., de los Santos T., Zhang C., Shokat K.Hollingworth N. M., Mol. Biol. Cell., 15, 11 - 23 (2004), "Mek1 Kinase Activity Functions Downstream of RED1 in the Regulation of Meiotic Double Strand Break Repair in Budding Yeast"
  • 8. Hindley A. D., Park S., Wang L., Shah K., Wang Y., Hu X., Shokat K. M., Kolch W., Sedivy J. M.Yeung K. C., FEBS Lett., 556, 26 - 34 (2004), "Engineering the Serine/Threonine Protein Kinase Raf-1 to Utilize an Orthogonal Analogue of ATP Substituted at the N6 Position"
  • 9. Kumar N. V., Eblen S. T.Weber M. J., Methods, 32, 389 - 397 (2004), "Identifying Specific Kinase Substrates through Engineered Kinases and ATP Analogs"
  • 10. Ulrich S. M., Kenski D. M.Shokat K. M., Biochemistry, 42, 7915 - 7921 (2003), "Engineering a 'Methionine Clamp' into Src Family Kinases Enhances Specificity toward Unnatural ATP Analogues"
  • 11. Eblen S. T., Kumar N. V., Shah K., Henderson M. J., Watts C. K. W., Shokat K. M.Weber M. J., J. Biol. Chem., 278, 14926 - 14935 (2003), "Identification of Novel ERK2 Substrates through Use of an Engineered Kinase and ATP Analogs"
  • 12. Habelhah H., Shah K., Huang L., Burlingame A. L., Shokat K. M.Ronai Z., J. Biol. Chem., 276, 18090 - 18095 (2001), "Identification of New JNK Substrate Using ATP Pocket Mutant JNK and a Corresponding ATP Analogue"
  • 13. Liu Y., Witucki L. A., Shah K., Bishop A. C.Shokat K. M., Biochemistry, 39, 14400 - 14408 (2000), "Src-Abl Tyrosine Kinase Chimeras: Replacement of the Adenione Binding Pocket of c-Abl with v-Src to Swap Nucleotide and Inhibitor Specifities"
  • 14. Gillespie P. G., Gillespie S. K. H., Mercer J. A., Shah K.Shokat K. M., J. Biol. Chem., 274, 31373 - 31381 (1999), "Engineering of the Myosin-Iß Nucleotide-binding Pocket to Create Selective Sensitivity to N6-modified ADP Analogs"
  • 15. Liu Y., Shah K., Yang F., Witucki L.Shokat K. M., Bioorg. Med. Chem., 6, 1219 - 1226 (1998), "A Molecular Gate which Controls Unnatural ATP Analogue Recognition by the Tyrosine Kinase v-Src"
  • 16. Moffat L. D., Brown S. B. A., Grassie M. E., Ulke-Lemée A., Williamson L. M., Walsh M. P.MacDonald J. A., J.Biol.Chem., 286, 36978 - 36991 (0), "Chemical Genetics of Zipper-interacting Protein Kinase Reveal Myosin Light Chain as a Bona Fide Substrate in Permeabilized Arterial Smooth Muscle"